Chemotherapy drug resistance — a panel discussion William L McGuireAntonio FojoRobert Ozols Viewpoints Pages: 133 - 144
Continuous 5-fluorouracil infusion in refractory carcinoma of the breast Richard HansenEdward QuebbemanRobert Ausman Reports Pages: 145 - 149
Four-drug sequential regimen in advanced breast cancer Laura FerrariEmilio BajettaGianni Bonadonna Reports Pages: 151 - 157
Familial and histological analyses of 138 breast cancer patients Nicole BürkiAndrej GencikHansjakob Müller Reports Pages: 159 - 167
Stimulation of breast cancer cellsin vitro by the environmental estrogen enterolactone and the phytoestrogen equol W. V. WelshonsC. S. MurphyV. C. Jordan Reports Pages: 169 - 175
Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis Peter J. WirthValgardur EgilssonSnorri S. Thorgeirsson Reports Pages: 177 - 189
Role of polyamines in the synthesis of prolactin-regulated growth factors by experimental breast cancer in culture Andrea ManniBetty BadgerGordon Luk Brief communication Pages: 191 - 196
Variations in lipoproteins during aminoglutethimide therapy J. BonneterreN. GhalimJC. Fruchart Brief communication Pages: 197 - 200
Alternating tamoxifen and medroxyprogesterone acetate in postmenopausal advanced breast cancer patients — short and long term endocrine effects Luciano CanobbioEnzo GalligioniFrancesco Boccardo Brief communication Pages: 201 - 204
Comment on prognosis in node negative breast cancer A. P. LockerR. W. Blamey Correspondence Pages: 205 - 205
Normal epithelial antigens recognized by GB3 and GB5 are diminished in intraductal and lost in infiltrating human breast carcinomas C -J G YehB -L HsiF Ettore Erratum Pages: 206 - 206
